S. Ruschel

Placebo-controlled study of tianeptine in major depressive episodes.

F. L. Rocha, J. A. Costa e Silva, D. Caetano, 1997, Neuropsychobiology.

Weight gain management in patients with schizophrenia during treatment with olanzapine in association with nizatidine.

M. S. De Lima, O. L. Bracco, S. Ruschel, 2006, Revista brasileira de psiquiatria.

Long-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia

R. Bressan, M. Louzã, P. Belmonte-de-Abreu, 2011, Neuropsychiatric disease and treatment.

[Factorial structure of the Hamilton depression scale. I].

J. Guelfi, P. Pichot, J. Dreyfus, 1981, Annales medico-psychologiques.

Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study

I. Bitter, T. Treuer, N. Dilbaz, 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Once‐daily duloxetine 60 mg in the treatment of major depressive disorder: Multicenter, double‐blind, randomized, paroxetine‐controlled, non‐inferiority trial in China, Korea, Taiwan and Brazil

Xiufeng Xu, J. Raskin, Min-Soo Lee, 2007, Psychiatry and clinical neurosciences.

Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study

J. Quevedo, R. Bressan, M. Louzã, 2014, Current medical research and opinion.

[The Checklist for Evaluation of Somatic Symptoms (CHESS). Its use in anxious and depressive pathology. Factor structure].

J. Guelfi, C. Pull, J. Dreyfus, 1983, Annales medico-psychologiques.